Research Group Cancer Cell Biology and Drug Discovery

Our mission is to eRASe Cancer!

The research goal of the Abankwa lab is to develop novel drug targeting strategies against the RAS pathway in cancer and developmental diseases called RASopathies.

Understand the normal functions of RAS for better drug targeting

Our research is focused on the major oncogene RAS. We study how RAS isoforms fundamentally impact on differentiation and stemness during cell differentiation and in cancer. We identify novel RAS drug targeting mechanisms and are developing proof-of-concept drugs. We employ quantitative fluorescence imaging, flow cytometry, biochemical and cellular assay development and molecular cell biology.

    Head of Group

    Prof. Daniel ABANKWA

    Full professor in Cellular Tumour Biology